Babatunde “Kay” Oyajobi, MBBS, PhD, MBA, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresa Lozano Long School of Medicine and UT Distinguished Teaching Professor at The University of Texas at San Antonio (UT San Antonio), has been elected to the 2026 class of Fellows of the American Society for Bone and Mineral Research (ASBMR).
ASBMR is the leading professional, scientific and medical society dedicated to advancing research that improves musculoskeletal health worldwide.

The ASBMR Fellow designation recognizes long-standing members who have demonstrated extraordinary commitment to the society through service or have made significant contributions to the field of bone and mineral research, including scholarly publications in the Journal of Bone and Mineral Research. Fellows are nominated by their peers and selected through a rigorous review process with final approval by the ASBMR Council.
“I am deeply honored to be elected a Fellow of the ASBMR, the premier scientific society advancing the bone, mineral and musculoskeletal research that shapes global discourse on skeletal health,” Oyajobi said. ” This recognition is profoundly meaningful to me; the ASBMR has been my scientific home since 1989, when I attended my first annual meeting in Montreal as a doctoral student. Throughout my career, I have benefited immensely from the generosity of mentors within the society and, in turn, it has been a privilege to serve the ASBMR through various volunteer roles and advocacy efforts.”
A cancer biologist, Oyajobi joined the Long School of Medicine faculty in 1999. His research focuses on understanding how multiple myeloma, the second most common blood cancer in adults, causes bone disease. His laboratory uses advanced cell and animal models to investigate tumor growth in bone and to evaluate promising therapeutic approaches aimed at improving outcomes for patients.
Over his three-decade career, Oyajobi has made significant contributions to the field of cancer-induced bone disease. Early in his career, he was named an ASBMR John Haddad Young Investigator. His work has been published in leading scientific journals, including the Journal of Bone and Mineral Research, Cancer Research, Clinical Cancer Research, Blood and Leukemia. His research has been supported by the National Institutes of Health, the Department of Defense and several local and national foundations.
Oyajobi earned his medical degree from the College of Medicine at the University of Lagos in Nigeria, his doctorate from the University of Sheffield in England and an MBA from The University of Texas at Austin.
He will be formally recognized alongside the 2026 class of Fellows at the ASBMR Annual Meeting in October in Boston.
